Medically SupervisedWeight Loss.
Built around your body. Backed by clinical science.
Clinician-supervised GLP-1 therapy with semaglutide and tirzepatide — delivering 15–20%+ total body weight loss in clinical trials. Personalized protocols built around your labs, metabolism, and goals. Serving Farmingdale, Long Island, and the NYC metro area.
A Clinical Approach to Lasting Results.
Medical weight loss is not a diet — it is a clinically supervised program that addresses the underlying biological, hormonal, and metabolic drivers of weight gain that willpower and commercial programs cannot reach. At RevitaLine Health in Farmingdale, NY, we provide GLP-1 receptor agonist therapy using semaglutide (Wegovy / Ozempic) and tirzepatide (Mounjaro / Zepbound) — the most clinically validated weight loss medications available today.
GLP-1 medications work by mimicking a natural gut hormone that regulates appetite, slows gastric emptying, and improves insulin sensitivity. Clinical trials have demonstrated average total body weight loss of 15–20%+ over 68 weeks — results that are simply not achievable through diet and exercise alone for most patients with metabolic dysfunction or obesity.
Unlike telehealth subscription services that mail medications without oversight, RevitaLine provides fully clinician-supervised care — including comprehensive lab work, metabolic assessment, ongoing dose management, and direct provider access. Every protocol is built around your individual biology, not a template.
How GLP-1 Therapy Works
GLP-1 (glucagon-like peptide-1) is a hormone naturally produced in the gut after eating. It signals the brain to reduce appetite, slows the rate at which food leaves the stomach, and stimulates insulin release in response to meals. GLP-1 receptor agonists are medications that mimic and amplify these effects — producing meaningful, sustained weight loss in ways that were previously only achievable through bariatric surgery.
Appetite Suppression
GLP-1 agonists act on receptors in the hypothalamus to reduce hunger signals and increase satiety — most patients report significantly reduced appetite within the first 1–2 weeks.
Slowed Gastric Emptying
By slowing the rate at which food moves from the stomach to the small intestine, GLP-1 medications extend fullness after meals — naturally reducing caloric intake without hunger.
Improved Insulin Sensitivity
GLP-1 agonists improve the body's response to insulin, reducing blood sugar spikes and addressing insulin resistance — a primary driver of metabolic weight gain.
Clinically Proven Results
The STEP trials showed 15% average weight loss with semaglutide. The SURMOUNT trials showed up to 22.5% with tirzepatide — results comparable to bariatric surgery without the procedure.
Cardiovascular Benefits
Beyond weight loss, GLP-1 therapy has demonstrated significant reductions in cardiovascular risk, blood pressure, and inflammatory markers — with FDA-approved cardiovascular indications.
Semaglutide vs Tirzepatide
Semaglutide targets GLP-1 receptors. Tirzepatide targets both GLP-1 and GIP receptors — producing greater average weight loss in trials. Your provider recommends the best fit for you.
A Comprehensive Clinical Program.
Every protocol is customized based on your labs, metabolic profile, and personal goals — not a one-size-fits-all approach.
GLP-1 Receptor Agonists
Semaglutide / Tirzepatide
Prescription weight loss medications with clinically proven results. GLP-1 agonists reduce appetite, improve insulin sensitivity, and drive meaningful, sustained weight loss under medical supervision.
Metabolic & Nutritional Support
Lab-Guided Optimization
Lab-guided dietary adjustments and supplementation tailored to your metabolic profile. We address nutritional deficiencies and support your body's natural fat-metabolism pathways.
Lifestyle & Behavioral Coaching
Evidence-Based Habits
Evidence-based habit optimization alongside medical treatment. Sustainable weight loss requires more than medication — we integrate behavioral strategy to support lasting change.
What to Expect — Week by Week
Most patients follow a predictable progression. Here's what the typical GLP-1 therapy journey looks like.
Starting Dose & Initial Adjustment
Your provider starts you on the lowest dose to allow your body to adjust. Mild nausea or reduced appetite may be noticed — this is normal and typically resolves quickly. Most patients notice reduced hunger within the first week.
Noticeable Appetite Changes
Appetite suppression becomes more pronounced. Food portions naturally decrease without effort or restriction. Most patients begin reporting meaningful weight loss by week 6–8 as the medication reaches therapeutic effect.
First Significant Results
The majority of patients see 5–10% body weight loss by month 3. Energy levels typically improve. Metabolic markers (blood sugar, cholesterol, blood pressure) often show measurable improvement by this point.
Accelerating Results
Weight loss continues to build. Dose may be increased to the next level based on response and tolerability. Most patients are firmly in their results phase with consistent weekly progress.
Goal Weight & Maintenance Transition
Clinical trials show 15–20%+ total body weight loss at 68 weeks. Your provider begins transitioning you to a maintenance protocol — building the habits and metabolic foundation to sustain your results long-term.
What's Your BMI?
Body Mass Index (BMI) is the primary screening metric used to determine candidacy for medical weight loss and GLP-1 therapy. Calculate yours below.
Enter your details and click Calculate to see your BMI.
BMI is a screening tool only and does not constitute medical advice or diagnosis. Candidacy for medical weight loss is determined by a licensed provider after clinical evaluation.
Not a Diet. A Clinical Program.
Most commercial programs ignore the underlying biology of weight gain. RevitaLine takes a different approach — addressing the root causes through lab-guided, clinician-supervised care.
Your Daily Calorie Needs
TDEE (Total Daily Energy Expenditure) is the number of calories your body burns each day. Understanding your TDEE is the foundation of any effective weight loss program — it tells us exactly how much of a deficit is needed to reach your goal weight.
Answers before your first visit.
Everything you want to know about GLP-1 therapy, candidacy, results, and what to expect from a clinically supervised program.
Average body weight loss with semaglutide
Average loss with tirzepatide in SURMOUNT trials
Duration of landmark clinical trials
Every protocol at RevitaLine